The first designs have been released of the housing-led redevelopment of GlaxoSmithKline’s former west London HQ, drawn up by ...

GSK chief executive Emma Walmsley said the new HQ is "an important next step" for the company, which has been under pressure of late following pipeline setbacks and an investor revolt.

Pharma firms are among many pausing diversity programmes and promising domestic investment ...

Amid a global spotlight on data protection and evolving privacy regulations, Syrenis ? the consent and preference management specialist behind the market-leading SaaS platform Cassie ? marks its 25th ...

Alector and GSK plan to complete trial enrollment by mid-2025 ... California to our South San Francisco Headquarters. Net Loss. For the quarter ended December 31, 2024, Alector reported a net loss of ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr ...

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next. ... Read More The post Biocurious: With Mayne Pharmaceuticals under takeover offer, ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...